MSI

Clinical trials for MSI explained in plain language.

Never miss a new study

Get alerted when new MSI trials appear

Sign up with your email to follow new studies for MSI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Terminated 1

Cancer drug combo shows promise for Hard-to-Treat bowel cancer

Disease control Terminated

This study tested a combination of two drugs (atezolizumab and bevacizumab) in 46 people with advanced colorectal cancer that had stopped responding to chemotherapy and had a specific genetic marker called MSI-like. The goal was to see if the combination could shrink tumors. The …

Matched conditions: MSI

Phase: PHASE2 • Sponsor: Vall d'Hebron Institute of Oncology • Aim: Disease control

Last updated May 17, 2026 03:45 UTC

MSI

Get alerted when new MSI trials appear

Cancer drug combo shows promise for Hard-to-Treat bowel cancer